Note Conversion Agreement and Warrant Amendment Sample Contracts

AMENDMENT NO. 2

Note Conversion Agreement and Warrant Amendment • October 3rd, 2014 • VistaGen Therapeutics, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Note Conversion Agreement and Warrant Amendment
• Filed
  October 3rd, 2014
• Company
  VistaGen Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

THIS AMENDMENT NO. 2 TO AMENDED AND RESTATED NOTE CONVERSION AGREEMENT AND WARRANT AMENDMENT (this “Agreement”) is entered into on September 30, 2014, by and between VistaGen Therapeutics, Inc., a Nevada corporation (the “Company”), and Platinum Long Term Growth VII, LLC, a Delaware limited liability company (“Platinum”).

AMENDED AND RESTATED NOTE CONVERSION AGREEMENT AND WARRANT AMENDMENT

Note Conversion Agreement and Warrant Amendment • July 22nd, 2014 • VistaGen Therapeutics, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Note Conversion Agreement and Warrant Amendment
• Filed
  July 22nd, 2014
• Company
  VistaGen Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

THIS AMENDED AND RESTATED NOTE CONVERSION AGREEMENT AND WARRANT AMENDMENT (this “Agreement”) is entered into on July 18, 2014, by and between VistaGen Therapeutics, Inc., a Nevada corporation (the “Company”), and Platinum Long Term Growth VII, LLC, a Delaware limited liability company (“Platinum”).

AMENDMENT NO. 1 TO AMENDED AND RESTATED NOTE CONVERSION AGREEMENT AND WARRANT AMENDMENT

Note Conversion Agreement and Warrant Amendment • September 4th, 2014 • VistaGen Therapeutics, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Note Conversion Agreement and Warrant Amendment
• Filed
  September 4th, 2014
• Company
  VistaGen Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

THIS AMENDMENT NO. 1 TO AMENDED AND RESTATED NOTE CONVERSION AGREEMENT AND WARRANT AMENDMENT (this “Agreement”) is entered into on September 2, 2014, by and between VistaGen Therapeutics, Inc., a Nevada corporation (the “Company”), and Platinum Long Term Growth VII, LLC, a Delaware limited liability company (“Platinum”).